Page last updated: 2024-10-31

midodrine and Acute Hepatic Failure

midodrine has been researched along with Acute Hepatic Failure in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research Excerpts

ExcerptRelevanceReference
"Terlipressin is an analog of the natural hormone arginine-vasopressin."6.44Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. ( Bendtsen, F; Borup, T; Krag, A; Møller, S, 2008)
"Terlipressin is an analog of the natural hormone arginine-vasopressin."2.44Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. ( Bendtsen, F; Borup, T; Krag, A; Møller, S, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krag, A1
Borup, T1
Møller, S1
Bendtsen, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy for the Control of Acute Variceal Bleeding in Patients With Liver Cirrhosis at a Tertiary Center in Mexico[NCT05331768]109 participants (Actual)Interventional2021-01-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for midodrine and Acute Hepatic Failure

ArticleYear
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Advances in therapy, 2008, Volume: 25, Issue:11

    Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Hepatorenal Syndrome; Hum

2008